JO
APYX icon

John Overdeck’s Apyx Medical APYX Stock Holding History

John Overdeck’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-22,788
Closed -$59.7K – 3016
2023
Q4 		$59.7K Sell
22,788
-1,112
-5% -$2.69K ﹤0.01% 2980
2023
Q3 		$76.5K Hold
23,900
– – ﹤0.01% 2770
2023
Q2 		$120K Buy
23,900
+5,100
+27% +$25.8K ﹤0.01% 2729
2023
Q1 		$54.1K Buy
+18,800
New +$54.9K ﹤0.01% 2744
2022
Q2 		– Sell
-17,369
Closed -$113K – 2492
2022
Q1 		$113K Buy
+17,369
New +$171K ﹤0.01% 2418
2021
Q4 		– Sell
-26,643
Closed -$369K – 4245
2021
Q3 		$369K Sell
26,643
-852
-3% -$8.96K ﹤0.01% 3506
2021
Q2 		$283K Buy
+27,495
New +$272K ﹤0.01% 3560
2019
Q1 		– Sell
-15,600
Closed -$101K – 3000
2018
Q4 		$101K Buy
+15,600
New +$94.5K ﹤0.01% 2810

Other funds holding APYX

ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCA
Greenwood Capital Associates Greenwood, South Carolina $1.02B AUM 28.26% 1-Year Est. Return

John Overdeck's APYX Position: Q1 2024 in Review

John Overdeck sold out of Apyx Medical (APYX) in Q1 2024, closing a stake of 22,788 shares — an estimated $59.7K sold.

John Overdeck first reported a position in APYX in Q4 2018 and held it in 8 quarters. The position peaked at $369K in Q3 2021. 51 funds tracked by Wall St. Rank hold APYX as of Q1 2024.

  • John Overdeck reported no remaining Apyx Medical position as of Q1 2024 after selling out during the quarter.
  • John Overdeck sold 22,788 Apyx Medical shares in Q1 2024, an estimated $59.7K.
  • John Overdeck first reported a position in Apyx Medical in Q4 2018 and held it in 8 quarters.
  • John Overdeck's Apyx Medical position peaked at $369K in Q3 2021.
  • 51 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2024.

Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.